IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 8859595 B1

PDFFull Text
Date of Patent:
Oct. 14, 2014

Filed:

Aug. 26, 2011

Potent and selective inhibitors of hepatitis c virus

Applicants:

Steven J. Coats, McDonough, GA (US);

Franck Amblard, Tucker, GA (US);

Hongwang Zhang, Tucker, GA (US);

Longhu Zhou, Atlanta, GA (US);

Richard Anthony Whitaker, Loganville, GA (US);

Tamara Rosario Mcbrayer, Atlanta, GA (US);

Raymond F. Schinazi, Miami, FL (US);

Junxing Shi, Duluth, GA (US);

Inventors:

Steven J. Coats, McDonough, GA (US);

Franck Amblard, Tucker, GA (US);

Hongwang Zhang, Tucker, GA (US);

Longhu Zhou, Atlanta, GA (US);

Richard Anthony Whitaker, Loganville, GA (US);

Tamara Rosario McBrayer, Atlanta, GA (US);

Raymond F. Schinazi, Miami, FL (US);

Junxing Shi, Duluth, GA (US);

Assignees:

RFS Pharma, LLC, Tucker, GA (US);

Emory University, Atlanta, GA (US);

Attorneys:

Hultquist, PLLC

David Bradin

Primary Examiner:

Samantha Shterengarts

Int. Cl.
CPC ...
A61K 31/4192 (2006.01); A61K 31/4178 (2006.01); C07D 249/04 (2006.01); C07D 403/02 (2006.01); C07D 403/14 (2006.01); A61K 31/444 (2006.01); A61K 31/655 (2006.01); C07D 413/14 (2006.01); C07D 401/14 (2006.01); A61K 45/06 (2006.01); C07D 405/14 (2006.01); C07D 403/04 (2006.01); A61K 31/506 (2006.01); A61K 31/5377 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4178 (2013.01); A61K 31/444 (2013.01); A61K 31/655 (2013.01); C07D 413/14 (2013.01); C07D 401/14 (2013.01); A61K 45/06 (2013.01); A61K 31/4192 (2013.01); C07D 405/14 (2013.01); C07D 403/04 (2013.01); A61K 31/506 (2013.01); C07D 403/14 (2013.01); A61K 31/5377 (2013.01);
Abstract

The present invention is directed to compounds, compositions and methods for treating or preventing hepatitis C virus (HCV) infection in human subjects or other animal hosts. The compounds are as also pharmaceutically acceptable, salts, prodrugs, and other derivatives thereof as pharmaceutical compositions and methods for treatment or prevention of HCV infection.

Find Patent Forward Citations

Loading…